By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144



Company News
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce RIZAPORT Commercialization Term Sheet With Pharmatronic Co. For Korea 9/21/2016 8:40:08 AM
RedHill Biopharma (RDHL) Announces Research Collaboration With Stanford University For YELIVA 9/12/2016 10:55:13 AM
RedHill Biopharma (RDHL) Announces Phase Ib/II Study With YELIVA Initiated For Multiple Myeloma At A Leading U.S. Academic Medical Center 9/8/2016 11:30:20 AM
RedHill Biopharma (RDHL) Announces Approval Of A European Patent Supporting RHB-104 For Multiple Sclerosis 8/29/2016 11:50:32 AM
RedHill Biopharma (RDHL) Provides 2016 Semi-Annual R&D Update 8/11/2016 12:20:23 PM
RedHill Biopharma (RDHL) Announces Last Patient Visit In Phase IIa Study With RHB-104 For Multiple Sclerosis 8/1/2016 10:43:29 AM
RedHill Biopharma (RDHL) Receives Additional U.S. Patent Covering RHB-105 Ahead Of Confirmatory Phase III Study For H. Pylori Infection 7/21/2016 9:31:20 AM
RedHill Biopharma (RDHL) Announces Research Collaboration With NIH For Potential Ebola Treatment 7/13/2016 9:20:17 AM
RedHill Biopharma (RDHL) To Present At Jefferies 2016 Healthcare Conference 5/31/2016 10:36:35 AM
RedHill Biopharma (RDHL) Announces National Cancer Institute Grant Supporting YELIVATM Phase II Hepatocellular Carcinoma Study 5/17/2016 9:42:52 AM